Related Experiment Video
Updated: Jul 26, 2025

Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
Published on: August 9, 2024
Epithelioid leiomyosarcoma: An unusual presentation.
Suman H Kalantri1, Leena Dennis Joseph1, N Priyathersini1
1Department of Pathology, Sri Ramachandra Institute of Higher Education and Research, Chennai, Tamil Nadu, India.
Epithelioid leiomyosarcoma (LMS) is a rare uterine malignancy. This case highlights the importance of histopathology and immunohistochemistry in diagnosing this aggressive tumor for effective patient treatment.
Area of Science:
- Gynecologic Oncology
- Surgical Pathology
- Medical Oncology
Background:
- Uterine mesenchymal tumors are diverse and can be difficult to diagnose.
- Leiomyosarcoma (LMS) is a rare uterine malignancy originating from smooth muscle tissue.
- LMS typically affects postmenopausal women and presents with abnormal uterine bleeding, often with an aggressive course and poor prognosis.
Observation:
- A 57-year-old menopausal woman presented with a large abdominal swelling.
- The swelling was observed to be infiltrating adjacent structures.
- Surgical resection was performed.
Findings:
- Histopathological evaluation confirmed a diagnosis of epithelioid LMS.
- Immunohistochemistry was utilized to confirm the diagnosis.
- Epithelioid LMS is a rare subtype of uterine sarcoma.
Implications:
- Accurate diagnosis of uterine mesenchymal tumors is crucial for appropriate treatment.
- Prompt diagnosis and surgical management are essential for patients with epithelioid LMS.
- This case underscores the role of advanced diagnostic techniques like immunohistochemistry in challenging oncological cases.
More Related Videos
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
07:18Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
Published on: June 13, 2019